Izet Karalic
Gent, VLG 9000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: April 03, 2026
Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents.
Journal: European journal of medicinal chemistry
Published: February 08, 2022
N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation.
Journal: European journal of medicinal chemistry
Published: November 22, 2021
6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents.
Journal: International journal for parasitology. Drugs and drug resistance
Published: June 11, 2021
Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents.
Journal: Journal of medicinal chemistry
Published: March 30, 2021
6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy.
Journal: ChemMedChem
Published: February 27, 2021
Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents.
Journal: European journal of medicinal chemistry
Published: November 05, 2020
Corrigenda to "Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents" [Bioorg Med Chem 24 (2016) 5172-5182].
Journal: Bioorganic & medicinal chemistry
Published: August 23, 2017
Micellar Paclitaxel-Initiated RAFT Polymer Conjugates with Acid-Sensitive Behavior.
Journal: ACS macro letters
Published: March 21, 2017
Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach.
Journal: Angewandte Chemie (International ed. in English)
Published: June 17, 2016
Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
Journal: Bioorganic & medicinal chemistry
Published: April 30, 2016
Last Updated: 09/26/2026